Drug Trial Radar · NCT02002247
SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).
Last checked: Nov 20, 2026Latest source record: Jun 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,400
Planned (sponsor's estimate)
Start
Jan 2015
Primary completion
Feb 2021
Study completion Jul 2021
Sponsor
- Lead sponsor
- Daren K. HeylandAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- biosyn Arzneimittel GmbH; Queen's University; RWTH Aachen University
- First posted
- Dec 5, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the investigators' research program is to investigate the effects of perioperative high dose selenium supplementation in high-risk cardiac surgical patients undergoing complicated open heart surgery. The investigators hypothesize that the therapeutic strategy tested in this randomized trial may contribute to a fewer complications, less organ injury and fewer deaths. Before the investigators conducted the large definitive trial, they conducted a pilot study to assess the feasibility of the protocol, and are rolling the pilot patients into the definitive trial.
Conditions
- Heart Disease
Interventions
sodium seleniteDrug
All subjects will receive an IV bolus of 2000µg selenium within 30min after induction of anesthesia via the central venous catheter. After termination of surgery, immediately after admission to the ICU, all patients will receive a second bolus of 2000µg selenium. Then on every further morning during ICU-stay, patients will receive an IV bolus of 1000µg selenium via central or peripheral venous access until death, discharge from ICU to the ward, or for a maximum of 10 days.
PlaceboDrug
All patients will receive an IV bolus of normal saline (equals to 40ml prepared solution) within 30min after induction of anesthesia via the central venous catheter. After termination of surgery, immediately after admission to the ICU, all patients will receive a second bolus of normal saline accordingly. Then on every further morning during ICU-stay, patients will receive an IV bolus of normal saline via central or peripheral venous access until death, discharge from ICU to the ward (treatment may continue in a step down or intermediate care unit), or for a maximum of 10 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- PODS free days + aliveTime frame: 30 Day
Locations
23 sites in 2 countries. Site status is shown where the registry gives one.
Hamilton General Hospital
Hamilton, Ontario, Canada
London Health Sciences Centre
London, Ontario, Canada
University of Ottawa Heart Institute
Ottawa, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Toronto General Hospital
Toronto, Ontario, Canada
Institut de cardiologie de Montreal
Montreal, Quebec, Canada
Sir Mortimer B. Davis Jewish General Hospital
Montreal, Quebec, Canada
McGill University Health Centre
Montreal, Quebec, Canada
Sacre Coeur
Montreal, Quebec, Canada
IUCPQ
Québec, Quebec, Canada
Centre de recherche CIUSSS de l'Estrie CHUS
Sherbrooke, Quebec, Canada
RWTH Aachen University Hospital
Aachen, Germany
Klinik und Poliklinik für Anästhesiologie und Operative Intensivmedizin Universitätsklinikum Bonn
Bonn, Germany
Klinik und Poliklinik für Herz- und Thoraxchirurgie Uniklinik Köln
Cologne, Germany
Universitätsklinikum Frankfurt
Frankfurt, Germany
Klinik für Her- und Gefäßchirurgie Universitäts-Herzzentrum Freiburg
Freiburg im Breisgau, Germany
Klinik für Herz-, Kinderherz- und Gefäßchirurgie UKGM Giessen
Giessen, Germany
University Medical Center Schleswig-Holstein
Kiel, Germany
Klinik für Anästhesiologie Universitätsmedizin Mainz
Mainz, Germany
Klinik für Anästhesiologie Klinikum der Universität München
München, Germany
Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie Universitätsmedizin Münster, Zentralklinikum
Münster, Germany
Klinikum Oldenburg gGmbH Universitätsklinik für Anästhesiologie / Intensivmedizin / Notfallmedizin / Schmerztherapie
Oldenburg, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.